Bormioli Pharma and Asamedic cooperate on the drug Coxor

Asamedic and Bormioli Pharma have entered into a partnership to market Coxor 300 mg acetylsalicylic acid, a drug for the emergency treatment of suspected acute myocardial infarction.

Since Coxor is available in liquid form, it represents a significant evolution from the traditional tablet format that must be swallowed with water or chewed. This innovation uses the EasyRec system, a state-of-the-art two-chamber packaging kit developed by Bormioli Pharma.

The EasyRec system allows for instant reconstitution of drug powders into a liquid, allowing patients to take the medication more quickly at critical moments. In addition, since the powder formulation is stored in the kit's cap until use, it is better protected from external influences such as moisture and oxygen.

Once reconstituted, the liquid form of Coxor does not require water. This speeds up self-administration in emergency situations and also ensures faster absorption of the medication into the bloodstream. This rapid delivery mechanism is critical in the treatment of heart attacks where timing is critical.

“Coxor™ is the first specifically approved over-the-counter emergency product for adults with heart attack symptoms with corresponding user characteristics,” said Geir Ivar Westen, CEO of Asamedic AS. “We started large-scale production in 2022 and can safely say that our partnership with Bormioli Pharma has been instrumental in ensuring the product provides the fastest and most effective treatment possible.”

Andrea Lodetti, CEO of Bormioli Pharma, added: “We are honored to launch Coxor together with Asamedic. This project is an example of how crucial early collaboration between pharmaceutical companies and packaging manufacturers can be in making medicines more accessible and effective, especially when it comes to life-saving medicines.”

Coxor has been approved in a European DCP process and tested in Norway. Asamedic is now looking for licensing and distribution partners in Europe and the rest of the world.